FSLR
73
15
EW
58
5
AME
72
6
DUK
52
-5
C
82
3
KR
37
-5
PGR
42
2
CME
45
3
NDAQ
74
4
KLAC
72
2
AVY
47
-7
PLD
30
2
O
33
2
LUV
68
2
ED
37
-6
CNP
49
-6
STZ
42
-2
HD
28
-4
QCOM
45
2
VFC
70
2
FSLR
73
15
EW
58
5
AME
72
6
DUK
52
-5
C
82
3
KR
37
-5
PGR
42
2
CME
45
3
NDAQ
74
4
KLAC
72
2
AVY
47
-7
PLD
30
2
O
33
2
LUV
68
2
ED
37
-6
CNP
49
-6
STZ
42
-2
HD
28
-4
QCOM
45
2
VFC
70
2
Financhill
Back

TD Canadian Bank Dividend Index ETF Vs. BioMarin Pharmaceutical, Inc. Industry Stock Comparison

Buy
55

TBNK.TO
TD Canadian Bank Dividend Index ETF

Last Price:
$41.71
Seasonality Move:
0.6%
Buy
54

BMRN
BioMarin Pharmaceutical, Inc.

Last Price:
$61.19
Seasonality Move:
5.52%
Buy
55
TD Canadian Bank Dividend Index ETF (TBNK.TO) is a Buy

Is TD Canadian Bank Dividend Index ETF a Buy, Sell or Hold?

  • The current TD Canadian Bank Dividend Index ETF [TBNK.TO] share price is $41.71. The Score for TBNK.TO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • TBNK.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
BioMarin Pharmaceutical, Inc. (BMRN) is a Buy

Is BioMarin Pharmaceutical, Inc. a Buy, Sell or Hold?

  • The current BioMarin Pharmaceutical, Inc. [BMRN] share price is $61.15. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TBNK.TO Stock Price Chart

What is TD Canadian Bank Dividend Index ETF's stock price today?

  • The TD Canadian Bank Dividend Index ETF share price today is $41.71
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBNK.TO is experiencing slight buying pressure.

BMRN Stock Price Chart

What is BioMarin Pharmaceutical, Inc.'s stock price today?

  • The BioMarin Pharmaceutical, Inc. share price today is $61.15
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMRN is experiencing slight buying pressure.

TBNK.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 7.78 Buy
Relative Strength Index (14 RSI): 74.45 Buy
Chaikin Money Flow: 5864 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.88 - 41.14) Buy
Bollinger Bands (100): (35.28 - 39.42) Buy

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.19 Buy
Relative Strength Index (14 RSI): 73.39 Buy
Chaikin Money Flow: 7836963 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.19 - 56.01) Buy
Bollinger Bands (100): (52.65 - 57.43) Buy

TBNK.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.32 Buy
20-day SMA: 40.41 Buy
50-day SMA: 38.93 Buy
200-day SMA: 34.04 Buy
8-day EMA: 21.91 Buy
20-day EMA: 10.72 Buy
50-day EMA: 4.67 Buy
200-day EMA: 1.22 Buy

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.6 Buy
20-day SMA: 54.21 Buy
50-day SMA: 53.61 Buy
200-day SMA: 57.94 Buy
8-day EMA: 54.44 Buy
20-day EMA: 53.99 Buy
50-day EMA: 54.1 Buy
200-day EMA: 58.28 Buy

TD Canadian Bank Dividend Index ETF Earnings Growth & TBNK.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

BioMarin Pharmaceutical, Inc. Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.97 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $1.68 per share.

TD Canadian Bank Dividend Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

BioMarin Pharmaceutical, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):